Specific Tumors and Respective Markers

   
 
 Table 8-4 Specific Tumors and Respective Markers
 Entity Positive Markers Negative Markers
 
Atypical
fibroxanthoma
(AFX)
Vimentin, actin, + histiocyte stains (i.e., CD68)
S100, pankeratin, CD34, CEA, EMA, desmin
 
Leiomyosarcoma
Desmin, smooth muscle actin, ± vimentin
CEA, S100 (only rarely positive), keratin (only rarely positive)
 
Melanoma
S100, vimentin, melanA, HMB45 (latter negative in desmoplastic / spindle cell melanoma)
Keratin CD45 (also known as leukocyte common antigen or LCA), CEA, EMA, desmin
 
Angiosarcoma
CD31, CD34, Factor VIII–related antigen, Ulex europaeus
Keratin, CEA, EMA, S100
 
Merkel cell
carcinoma
(MCC)
CK 20, EMA, NSE, synaptophysin, chromogranin
S100, CD45, CEA, vimentin, desmin, GFAP, thyroid transcription factor-1 or TTF-1
 
Schwannoma
(Neurilemmoma)
Vimentin, S100, MBP
Keratin, neurofilaments, desmin
 
Glomus tumor
Vimentin, smooth muscle actin
Desmin (occasionally focally positive), cytokeratin
 
Epithelioid sarcoma
Cytokeratin, CD34 (50% cases), EMA, vimentin, ± CEA
 
DFSP
Vimentin, CD34
S100, HMB45, keratin,
stromelysin-3, Factor XIIIa
(latter two markers positive in dermatofibroma)
 
Paget’s disease
CK7, EMA, CEA, GCDFP-15
S100, HMB45
 
Sebaceous carcinoma
EMA, keratin (CAM 5.2)
CEA (usually), S100
 
Granular cell tumor
S100, NSE, MBP
GFAP, neurofilament